Figure S4 from TAS-114, a First-in-Class Dual dUTPase/DPD Inhibitor, Demonstrates Potential to Improve Therapeutic Efficacy of Fluoropyrimidine-Based Chemotherapy
crossref（2023）
摘要
Expression levels of dUTPase in various tumor xenografts and antitumor efficacy of S-1 and TAS-114 combination in various xenograft models
查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要